大家在查：策源地 CraigBarrett 贝斯手感觉统 sonography untroubled 美观大方 mistiming Sadie 阿贝拉•哈梅德

他滨

网络Emtricitabine; Xeloda; Gem zar

他滨

他滨

Emtricitabine

...的随机对照研究也提示，泛西洛韦与LMV, 以及恩典他滨（Emtricitabine）与ADV联合治疗对病毒的抑制力，分别高于单独LM…

Xeloda

...（Oral 5-FU prodrugs ）:卡培他滨(Xeloda)和 S-1; 拓扑异构酶I抑制剂:伊立替康（CPT-11）。

Gem zar

... 他滨( Gem zar) 、氟尿嘧啶(5-FU)和BLM的平均抑制率分别为47.6% 、 ... 来自互联网 5. We called these FCA entrapped 5 …

1

A recent phase III trial of the combination of gemcitabine with erlotinib was associated with a significant prolongation of survival .

一项最新的 III 期试验显示吉西他滨联合厄罗替尼布可以显著延长生存期。

2

Gemcitabine induced apoptosis and necrosis of purified MDSC in vitro in a time dependent manner.

体外吉西他滨时间依赖性诱导 MDSC 凋亡与坏死；

3

abstract: Decitabine is now as the first-line drug for the treatment of myelodysplastic syndrome because of its certain effect .

地西他滨对骨髓增生异常综合征有肯定疗效，目前已成为治疗该病的一线用药。

6

Gemzar treatment is now considered the standard of care for pancreatic cancer following surgery .

吉西他滨目前是作为胰腺癌术后的标准治疗药物。

7

Gemcitabine is generally accepted as the standard chemotherapeutic agent for advanced pancreatic cancer .

以吉西他滨为基础的化疗是胰腺癌的主要治疗方法。

8

Hand-and-foot syndrome (HFS) is one of the well-known adverse events associated with capecitabine , a prodrug of 5-fluorouracil (5-FU).

手和脚综合征（痉挛）是一种众所周知的不良事件与卡培他滨，一个药 5 氟尿嘧啶（5-FU ）。

11

Many pancreatic tumor cells are resistant to gemcitabine , which makes the disease very difficult to treat , explained Govindarajan.

很多胰腺肿瘤细胞对吉西他滨耐药，导致这种疾病现在很难得到有效治疗。

12

Erlotinib is also being evaluated in combination with capecitabine in patients who failed first-line therapy with gemcitabine .

厄罗替尼布联合卡培他滨同样用于一线药物吉西他滨治疗失败的患者。

13

ObjectiveTo evaluate the efficacy and safety of bevacizumab plus capecitabine in treating metastatic colorectal cancer(mCRC).

目的观察贝伐单抗联合卡培他滨治疗转移性结直肠癌的疗效及不良反应。

18

Decitabine is the most common medicament used to reduce the level of methylation .

地西他滨是用于降低甲基化的常用药物。

19

Results In primary breast cancer , the antitumor effect of taxane is better than anthracycline and gemcitabine (P 0 . 01 ).

对复发性乳腺癌患者，吉西他滨的疗效则明显优于蒽环类和紫杉类药物（P0 。01 ）。

21

Toxic effects of capecitabine and fluorouracil were similar .

卡培他滨和氟尿嘧啶的毒副作用相似。

22

Eligible patients were randomized to either treatment with gemcitabine alone (204 participants) or in combination with cisplatin (206 ).

这些满足适应症的患者被随机分至单用吉西他滨组（204 例）和顺铂 -吉西他滨联用组（206 例）。

23

The next study that I want to discuss is a study comparing tenofovir vs tenofovir and emtricitabine in adefovir-experienced patients .

接下来的学习，我想讨论的是一个比较研究阿德福韦的患者替诺福韦与替诺福韦和恩曲他滨。

24

Capacitabine demonstrated a response rate of 34% in a phase II trial from Korea .

在一个韩国的 II 期临床中卡培他滨单药治疗晚期胃癌的缓解率为 34%。

26

After treatment with gemcitabine and CD40 antibody , the tumors shrank in 30% of the animals.

采用吉西他滨和 CD40 抗体治疗后，30%的小鼠肿瘤瘤体缩小。

27

The total yield of gemcitabine was 15 . 8%.

结果：合成了盐酸吉西他滨，总收率 15 .

29

The median survival for patients taking both Avastin and Gemzar was 5 . 7 months compared with 6. 0 months for patients taking Gemzar alone.

吉西他滨合用贝伐单抗的患者中位生存期为 5.7个月，而单用吉西他滨者为 6个月。

30

热词推荐

大家在看